Le Lézard
Classified in: Health, Science and technology
Subject: PER

DLH Appoints Gil Tadmor as Corporate Chief Technology Officer


ATLANTA, Sept. 12, 2018 /PRNewswire/ -- DLH Holdings Corp. (NASDAQ: DLHC) announced today it has appointed Gil Tadmor as corporate Chief Technology Officer (CTO) to manage its technology and innovation initiatives, emphasizing health information technology (IT), big data, and data analytics for current client programs and future growth opportunities. Focus will include programs and opportunities at the Departments of Defense, Health and Human Services, Homeland Security, Veterans Affairs; Defense Health Agency; Defense Logistics Agency; and other Federal agencies. He will report to President and Chief Executive Officer Zachary Parker and support each of DLH's operating units in implementing a long-term technology strategy for the company.

DLH Appoints Gil Tadmor as Corporate Chief Technology Officer

Mr. Tadmor is a highly respected industry leader, with more than 30 years' experience with software architecture, business intelligence and analytics, solution ideation and creation, agile systems development, cloud migration, and IT systems modernization. Since joining DLH in 2015, he has led the company's efforts in achieving Capability Maturity Model Integration certification, winning a G2X Federal Health IT Innovation Award, and redesigning and migrating a large-scale Federal legacy health IT system. Prior to joining DLH, he served in technology leadership roles with SCI Group, Gene Logic, Corvis Corporation, and Raytheon 

In assuming this new role, Mr. Tadmor stated, "It is with great respect and honor that I take on the role of corporate CTO at DLH. With our incredible team of experts and our awesome company culture, I am confident that together we can crystalize our position as a leading technology-enabled service and solutions provider to our clients."

Mr. Parker said, "Gil has demonstrated a strong commitment to performance excellence, process improvement, and innovation while consistently focusing on achieving maximum customer satisfaction. I am confident Gil's addition to our senior leadership team will further enhance DLH's value to our customers and the special populations we serve across the Nation."

About DLH
DLH (NASDAQ: DLHC) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. The company's core competencies include assessment and compliance monitoring, business process outsourcing, health information technology systems integration and management, readiness and medical logistics, and pharmacy solutions. DLH has more than 1,400 employees working throughout the country. For more information, visit the corporate website at www.dlhcorp.com.

 CONTACTS:

COMMUNICATIONS


INVESTOR RELATIONS

Contact: Tiffany McCall


Contact: Chris Witty

Phone: 404?334?6000


Phone:646?438?9385

Email:[email protected]


Email:[email protected]

 

 

DLH Logo (PRNewsfoto/DLH Holdings Corp.)

SOURCE DLH Holdings Corp.


These press releases may also interest you

at 11:40
Donaldson Company, Inc. , a leading worldwide provider of innovative filtration products and solutions, announced its Isolere Bio (Isolere) and Univercells Technologies businesses are developing an integrated upstream and downstream platform for...

at 11:39
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA. The newly built 154,000-square-foot lab and...

at 11:30
Hercules Tires is excited to announce that throughout May, it will partner with five NCAA Division I conferences for its first-ever, conference-wide campaign to coincide with Mental Health Awareness Month. The partnership will help raise awareness...

at 11:30
Smash Iron Fitness, a renowned premier gym located in the heart of Las Vegas, NV, is excited to announce the launch of their new personal training transformational packages....

at 11:30
CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical...

at 11:29
The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell transplants (HCT) for eligible Medicare patients with myelodysplastic syndromes (MDS), based on decades-long...



News published on and distributed by: